Reaction profile

The FDA adverse-event record for palpitation

45 FDA reports name palpitation, a lower-volume reaction in the CVM extract (VeDDRA 1670). Plate stamps and neighbourhood peers follow.

#1797 of 2,481
by report volume (all reactions)
45
reports citing this reaction
17.8%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Palpitation has 45 reports now versus 43 in that prior snapshot: 2 more (4.7%).

Report change
+2
Death-coded reports
+0
Death-coded share
−0.8 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Palpitation changes

FDA AER · VeDDRA plate

Code 1670 VOL-TRACE

VOL-TRACE · DEATH-ELEV · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 45 reports
  • DEATH-ELEV 17.8%
  • MID-PACK #1797/2481
  • PHOTO-FINISH Application site disc…
  • SPECIES-DOG Dog · 31
  • DRUG-LEAD Oclacitinib Malea… · 6
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Application site discharge NOS (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Palpitation

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Application site disc… · near45Buccal irritation · near45Chest tightness · near45Flaccid paralysis · near45Palpitation · this reaction45Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Palpitation

What the FDA AER plate says about Palpitation

Signature read: 45 reports place Palpitation in the lower third of FDA AER volume (#1797 of 2,481). Report volume is lower-third scale: 45 named reports in the openFDA extract. 8 of 45 reports were death-coded (17.8% of named reports, not a population mortality rate). Nearest volume peer: Application site discharge NOS (±0 reports). Lead species Dog (31). Lead co-reported drug Oclacitinib Maleate (6).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Oclacitinib Maleate appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 31
Human 11
Cat 3

Breeds Most Affected

Unknown 11
Shepherd Dog - German 4
Terrier - Jack Russell 3
Terrier - Yorkshire 3
Maltese 3
Retriever - Labrador 2
Shih Tzu 2
Chihuahua 2
Domestic Shorthair 2
Schipperke 2

Associated Drugs

Oclacitinib Maleate 6
Gabapentin 5
Milbemycin Oxime + Spinosad 4
Ivermectin + Pyrantel As Pamoate Salt 3
Maropitant Citrate 3
Phenylpropanolamine Hydrochloride 3
Bedinvetmab 3
Polysulfated Glycosaminoglycan 3
Pimobendan 3
Telmisartan 3
Trilostane 2
Spinosad 2
Prednisolone; Trimeprazine Tartrate 2
Tilmicosin 2
Emodepside + Praziquantel 2
Grapiprant 2
Carprofen (Unknown) 2
Tramadol 2
Pancreatic Supplement 2
Vaccines (Unknown) 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Palpitation (#1797 of 2,481 by report volume); death-coded 17.8%. PlainBreed reaction plate · report volume stamp 45 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →